RECURSION PHARMACEUTICALS, INC. (RXRX) Gross profit 2020–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) annual gross profit history from SEC filings — each fiscal year as reported.
$3.7MFY2025 · since FY2020: $4.0M → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7M | -72.6% |
| FY2024 | $13.6M | +584.2% |
| FY2023 | $2.0M | +123.6% |
| FY2022 | -$8.4M | -182.8% |
| FY2021 | $10.2M | +156.9% |
| FY2020 | $4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice